CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($) $ in Thousands	Total	Series A Preferred Stock	Series B Preferred Stock	Shares of Common Stock Outstanding	Shares of Preferred Stock Series A Preferred Stock	Shares of Preferred Stock Series B Preferred Stock	Treasury Stock Preferred and Common Stock	Common Stock and Additional Paid-in Capital	Preferred Stock Series A Preferred Stock	Preferred Stock Series B Preferred Stock	Accumulated Deficit
Balance at Dec. 31, 2023	$ 185							$ 63,059	$ 426	$ 18,602	$ (81,902)
Balance (in shares) at Dec. 31, 2023				1,839,000			(11,000)
Balance (in shares) at Dec. 31, 2023					560,000	2,252,000
Stock-based compensation	43							43
Net loss	(962)										(962)
Balance at Mar. 31, 2024	(734)							63,102	426	18,602	(82,864)
Balance (in shares) at Mar. 31, 2024				1,839,000			(11,000)
Balance (in shares) at Mar. 31, 2024					560,000	2,252,000
Balance at Dec. 31, 2023	185							63,059	426	18,602	(81,902)
Balance (in shares) at Dec. 31, 2023				1,839,000			(11,000)
Balance (in shares) at Dec. 31, 2023					560,000	2,252,000
Net loss	(1,668)
Balance at Jun. 30, 2024	(1,417)							63,125	426	18,602	(83,570)
Balance (in shares) at Jun. 30, 2024				1,904,000			(11,000)
Balance (in shares) at Jun. 30, 2024					560,000	2,252,000
Balance at Mar. 31, 2024	(734)							63,102	426	18,602	(82,864)
Balance (in shares) at Mar. 31, 2024				1,839,000			(11,000)
Balance (in shares) at Mar. 31, 2024					560,000	2,252,000
Stock-based compensation	23							23
Restricted stock issuance (in shares)				65,000
Net loss	(706)										(706)
Balance at Jun. 30, 2024	(1,417)							63,125	426	18,602	(83,570)
Balance (in shares) at Jun. 30, 2024				1,904,000			(11,000)
Balance (in shares) at Jun. 30, 2024					560,000	2,252,000
Balance at Dec. 31, 2024	$ (2,919)							63,173	426	18,602	(85,120)
Balance (in shares) at Dec. 31, 2024	1,890,000			1,879,000			(11,000)
Balance (in shares) at Dec. 31, 2024		559,000	2,252,000		560,000	2,252,000
Stock-based compensation	$ 22							22
Common stock issued in connection with Preferred Stock Series B dividends (in shares)				250,000
Common stock issued in connection with Preferred Stock Series B dividends								603			(603)
Net loss	(1,262)										(1,262)
Balance at Mar. 31, 2025	(4,159)							63,798	426	18,602	(86,985)
Balance (in shares) at Mar. 31, 2025				2,129,000			(11,000)
Balance (in shares) at Mar. 31, 2025					560,000	2,252,000
Balance at Dec. 31, 2024	$ (2,919)							63,173	426	18,602	(85,120)
Balance (in shares) at Dec. 31, 2024	1,890,000			1,879,000			(11,000)
Balance (in shares) at Dec. 31, 2024		559,000	2,252,000		560,000	2,252,000
Net loss	$ (2,711)
Balance at Jun. 30, 2025	$ (5,454)							63,952	426	18,602	(88,434)
Balance (in shares) at Jun. 30, 2025	2,253,000			2,242,000			(11,000)
Balance (in shares) at Jun. 30, 2025		559,263	2,252,272		560,000	2,252,000
Balance at Mar. 31, 2025	$ (4,159)							63,798	426	18,602	(86,985)
Balance (in shares) at Mar. 31, 2025				2,129,000			(11,000)
Balance (in shares) at Mar. 31, 2025					560,000	2,252,000
Stock-based compensation	25							25
Exercise of stock options	129							129
Exercise of stock options (in shares)				48,000
Restricted stock issuance (in shares)				65,000
Net loss	(1,449)										(1,449)
Balance at Jun. 30, 2025	$ (5,454)							$ 63,952	$ 426	$ 18,602	$ (88,434)
Balance (in shares) at Jun. 30, 2025	2,253,000			2,242,000			(11,000)
Balance (in shares) at Jun. 30, 2025		559,263	2,252,272		560,000	2,252,000